Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 5, 2005 - Issue 1
Submit an article Journal homepage
221
Views
22
CrossRef citations to date
0
Altmetric
Review

Towards a healthier discount procedure

Rogier M Klock University of Groningen, Groningen University, Institute for Drug Exploration, Research Institute of Pharmacy (GUIDE/GRIP), Groningen, The Netherlands
,
Werner BF Brouwer Institute of Medical Technology Assessment (iMTA), Rotterdam, The Netherlands
,
Lieven JP Annemans Ghent University, Ghent & IMS Health, Health Economics and Outcomes Research, Brussels, Belgium
,
Jasper M Bos University of Groningen, Groningen University, Institute for Drug Exploration, Research Institute of Pharmacy (GUIDE/GRIP), Groningen, The Netherlands
&
Maarten J Postma University of Groningen, Groningen University, Institute for Drug Exploration, Research Institute of Pharmacy (GUIDE/GRIP), Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. [email protected]
Pages 59-63 | Published online: 09 Jan 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Baudouin Standaert & Olivier Ethgen. (2023) Discounting health gain: a different view. Journal of Market Access & Health Policy 11:1.
Read now
Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma & Mondher Toumi. (2020) Health economic evaluation of gene replacement therapies: methodological issues and recommendations. Journal of Market Access & Health Policy 8:1.
Read now
Didik Setiawan, Jos Luttjeboer, Tjalke Arend Westra, Jan C Wilschut, Auliya A Suwantika, Toos Daemen, Jarir Atthobari, Bob Wilffert & Maarten J Postma. (2015) The cost–effectiveness of HPV vaccination in addition to screening: a Dutch perspective. Expert Review of Vaccines 14:4, pages 589-604.
Read now
Mehraj BY Parouty, Daan GM Krooshof, Tjalke A Westra, Petros Pechlivanoglou & Maarten J Postma. (2013) Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time. Expert Review of Pharmacoeconomics & Outcomes Research 13:4, pages 523-547.
Read now
Maarten J Postma, Tjalke A Westra, Sibilia Quilici & Nathalie Largeron. (2013) Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples. Expert Review of Vaccines 12:5, pages 555-565.
Read now
Maarten J Postma, Mehraj Parouty & Tjalke A Westra. (2013) Accumulating evidence for the case of differential discounting. Expert Review of Clinical Pharmacology 6:1, pages 1-3.
Read now

Articles from other publishers (16)

Jürgen John, Florian Koerber & Mareike Schad. (2019) Differential discounting in the economic evaluation of healthcare programs. Cost Effectiveness and Resource Allocation 17:1.
Crossref
Arthur E. Attema, Werner B. F. Brouwer & Karl Claxton. (2018) Discounting in Economic Evaluations. PharmacoEconomics 36:7, pages 745-758.
Crossref
Bernhard Ultsch, Oliver Damm, Philippe Beutels, Joke Bilcke, Bernd Brüggenjürgen, Andreas Gerber-Grote, Wolfgang Greiner, Germaine Hanquet, Raymond Hutubessy, Mark Jit, Mirjam Knol, Rüdiger von Kries, Alexander Kuhlmann, Daniel Levy-Bruhl, Matthias Perleth, Maarten Postma, Heini Salo, Uwe Siebert, Jürgen Wasem & Ole Wichmann. (2015) Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community. PharmacoEconomics 34:3, pages 227-244.
Crossref
M. B. Y. Parouty, H. H. Le, D. Krooshof & M. J. Postma. (2014) Differential Time Preferences for Money and Quality of Life. PharmacoEconomics 32:4, pages 411-419.
Crossref
JOEP THIJSSEN, M. ELSKE VAN DEN AKKER VAN MARLE, C. JAN WILLEM BORLEFFS, JOHANNES B. VAN REES, MIHÁLY K. DE BIE, ENNO T. VAN DER VELDE, LIESELOT VAN ERVEN & MARTIN J. SCHALIJ. (2013) Cost‐Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry. Pacing and Clinical Electrophysiology 37:1, pages 25-34.
Crossref
Maarten Postma & Cornelis Boersma. 2014. Handboek farmaceutische geneeskunde. Handboek farmaceutische geneeskunde 99 118 .
Tjalke A. Westra, Mehraj Parouty, Werner B. Brouwer, Philippe H. Beutels, Raina M. Rogoza, Mark H. Rozenbaum, Toos Daemen, Jan C. Wilschut, Cornelis Boersma & Maarten J. Postma. (2012) On Discounting of Health Gains from Human Papillomavirus Vaccination: Effects of Different Approaches. Value in Health 15:3, pages 562-567.
Crossref
Mareike Schad & Jürgen John. (2010) Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis. The European Journal of Health Economics 13:2, pages 127-144.
Crossref
James F. O'Mahony, Inge M.C.M. de Kok, Joost van Rosmalen, J. Dik F. Habbema, Werner Brouwer & Marjolein van Ballegooijen. (2011) Practical Implications of Differential Discounting in Cost-Effectiveness Analyses with Varying Numbers of Cohorts. Value in Health 14:4, pages 438-442.
Crossref
C. Krauth, J. John & M. Suhrcke. (2011) Gesundheitsökonomische Methoden in der PräventionHealth economic evaluation in prevention. Prävention und Gesundheitsförderung 6:2, pages 85-93.
Crossref
Maarten J. Postma. (2010) Cost-effectiveness analysis of Human Papillomavirus (HPV) Vaccination in the Netherlands: Recent publication reinforces favorable cost-effectiveness despite misleading conclusion. Vaccine 28:4, pages 873-874.
Crossref
Robin de Vries, Rogier M. Klok, Jacobus R.B.J. Brouwers & Maarten J. Postma. (2009) Cost-effectiveness of a potential future Helicobacter pylori vaccine in the Netherlands: The impact of varying the discount rate for health. Vaccine 27:6, pages 846-852.
Crossref
G.A.A. Hubben, J.M. Bos, D.M. Glynn, A. van der Ende, L. van Alphen & M.J. Postma. (2007) Enhanced decision support for policy makers using a web interface to health-economic models—Illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands. Vaccine 25:18, pages 3669-3678.
Crossref
Cornelis Boersma, George W. Carides, Jarir Atthobari, Adriaan A. Voors & Maarten J. Postma. (2007) An economic assessment of losartan-based versus atenolol-based therapy in patients with hypertension and left-ventricular hypertrophy: Results from the losartan intervention for endpoint reduction (LIFE) study adapted to The Netherlands. Clinical Therapeutics 29:5, pages 963-971.
Crossref
Maarten J Postma, Annoesjka Novak, Huib W K F H Scheijbeler, Marlene Gyldmark, Marianne L L van Genugten & Jan C Wilschut. (2007) Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza. PharmacoEconomics 25:6, pages 497-509.
Crossref
J M Bos, M J Postma & L Annemans. (2006) The Authors??? Reply. PharmacoEconomics 24:12, pages 1275-1276.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.